Fusen Pharmaceutical Salute del bilancio
Salute finanziaria criteri di controllo 1/6
Fusen Pharmaceutical has a total shareholder equity of CN¥519.2M and total debt of CN¥347.9M, which brings its debt-to-equity ratio to 67%. Its total assets and total liabilities are CN¥1.3B and CN¥818.2M respectively.
Informazioni chiave
67.0%
Rapporto debito/patrimonio netto
CN¥347.94m
Debito
| Indice di copertura degli interessi | n/a |
| Contanti | CN¥2.82m |
| Patrimonio netto | CN¥519.16m |
| Totale passività | CN¥818.21m |
| Totale attività | CN¥1.34b |
Aggiornamenti recenti sulla salute finanziaria
Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
May 21
Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
Dec 14Here's Why Fusen Pharmaceutical (HKG:1652) Can Manage Its Debt Responsibly
Sep 02Fusen Pharmaceutical (HKG:1652) Seems To Use Debt Quite Sensibly
Apr 02Does Fusen Pharmaceutical (HKG:1652) Have A Healthy Balance Sheet?
Dec 28Recent updates
Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
May 21Fusen Pharmaceutical Company Limited's (HKG:1652) Popularity With Investors Under Threat As Stock Sinks 27%
Mar 31Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
Dec 14Here's Why Fusen Pharmaceutical (HKG:1652) Can Manage Its Debt Responsibly
Sep 02Fusen Pharmaceutical (HKG:1652) Seems To Use Debt Quite Sensibly
Apr 02A Look At Fusen Pharmaceutical's (HKG:1652) Share Price Returns
Mar 06We Wouldn't Rely On Fusen Pharmaceutical's (HKG:1652) Statutory Earnings As A Guide
Feb 08
Is Fusen Pharmaceutical Company Limited's (HKG:1652) Recent Price Movement Underpinned By Its Weak Fundamentals?
Jan 18Does Fusen Pharmaceutical (HKG:1652) Have A Healthy Balance Sheet?
Dec 28What You Need To Know About Fusen Pharmaceutical Company Limited's (HKG:1652) Investor Composition
Dec 07If You Had Bought Fusen Pharmaceutical (HKG:1652) Shares A Year Ago You'd Have Earned 34% Returns
Nov 20Analisi della posizione finanziaria
Passività a breve termine: 1652's short term assets (CN¥504.2M) do not cover its short term liabilities (CN¥690.8M).
Passività a lungo termine: 1652's short term assets (CN¥504.2M) exceed its long term liabilities (CN¥127.4M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 1652's net debt to equity ratio (66.5%) is considered high.
Riduzione del debito: 1652's debt to equity ratio has increased from 26.6% to 67% over the past 5 years.
Copertura del debito: 1652's operating cash flow is negative, therefore debt is not well covered.
Copertura degli interessi: Insufficient data to determine if 1652's interest payments on its debt are well covered by EBIT.